NONO and tumorigenesis: More than splicing

J Cell Mol Med. 2020 Apr;24(8):4368-4376. doi: 10.1111/jcmm.15141. Epub 2020 Mar 13.

Abstract

The non-POU domain-containing octamer-binding protein NONO/p54nrb , which belongs to the Drosophila behaviour/human splicing (DBHS) family, is a multifunctional nuclear protein rarely functioning alone. Emerging solid evidences showed that NONO engages in almost every step of gene regulation, including but not limited to mRNA splicing, DNA unwinding, transcriptional regulation, nuclear retention of defective RNA and DNA repair. NONO is involved in many biological processes including cell proliferation, apoptosis, migration and DNA damage repair. Dysregulation of NONO has been found in many types of cancer. In this review, we summarize the current and fast-growing knowledge about the regulation of NONO, its biological function and implications in tumorigenesis and cancer progression. Overall, significant findings about the roles of NONO have been made, which might make NONO to be a new biomarker or/and a possible therapeutic target for cancers.

Keywords: DBHS; NONO; splicing; tumorigenesis.

Publication types

  • Review

MeSH terms

  • Apoptosis / genetics
  • Carcinogenesis / genetics*
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • DNA Repair / genetics
  • DNA-Binding Proteins / genetics*
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Neoplasms / genetics*
  • RNA Splicing / genetics
  • RNA-Binding Proteins / genetics*

Substances

  • DNA-Binding Proteins
  • NONO protein, human
  • RNA-Binding Proteins